Effect of atorvastatin on hypercholesterolemia and endothelium-dependent vasodilatation
Li Yang
Abstract
Li Yang
Abstract
ObjectiveTo investigate the effect of atorvastatin on hypercholesterolemia and endothelium-dependent vasodilatation.Methods42 hypercholesterolemic patients took atorvastatin for 8 weeks, and serum cholesterol was measured before and after the treatment. High-resolution ultrasound endothelium-dependent vasodilatation was measured in hypercholesterolemic group before and after the treatment, with 40 healthy subjects as the control group.ResultsThe flow-induced dilation of the brachial artery of hypercholesterolemic group was (3.66±0.72)% much reduced compared with that of the control subjects (13.18±1.23)% ( P 0.001). After 8 weeks treated by atorvastatin 10~20 mg/d, flow-induced dilation of the brachial artery of hypercholesterolemic group increased to (10.98±1.57)% much improved ( P0.001), and serum cholesterole declined from (7.11±0.70) mmol/L to ( 5.86±0.59) mmol/L ( P0.01).ConclusionHypercholesterolemic patients have endothelium-dependent vasodilatation dysfunction, atorvastatin not only reduces cholesterole but also recovers endothelium vasodilatation function.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
ObjectiveTo investigate the effect of atorvastatin on hypercholesterolemia and endothelium-dependent vasodilatation.Methods42 hypercholesterolemic patients took atorvastatin for 8 weeks, and serum cholesterol was measured before and after the treatment. High-resolution ultrasound endothelium-dependent vasodilatation was measured in hypercholesterolemic group before and after the treatment, with 40 healthy subjects as the control group.ResultsThe flow-induced dilation of the brachial artery of hypercholesterolemic group was (3.66±0.72)% much reduced compared with that of the control subjects (13.18±1.23)% ( P 0.001). After 8 weeks treated by atorvastatin 10~20 mg/d, flow-induced dilation of the brachial artery of hypercholesterolemic group increased to (10.98±1.57)% much improved ( P0.001), and serum cholesterole declined from (7.11±0.70) mmol/L to ( 5.86±0.59) mmol/L ( P0.01).ConclusionHypercholesterolemic patients have endothelium-dependent vasodilatation dysfunction, atorvastatin not only reduces cholesterole but also recovers endothelium vasodilatation function.
Key concepts: Atorvastatin, Brachial artery, Vasodilation, Endothelium, Medicine, Internal medicine, Cardiology, Endothelial dysfunction